OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Gastroenterology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
An updated overview of spectrum of gluten-related disorders: clinical and diagnostic aspects	70
Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study	59
The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study	58
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study	53
Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis	51
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis	47
Sedation practices for routine gastrointestinal endoscopy: a systematic review of recommendations	45
The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis	45
Adverse events of video capsule endoscopy over the past two decades: a systematic review and proportion meta-analysis	44
The global, regional, and national burden of acute pancreatitis in 204 countries and territories, 1990–2019	44
Dietary patterns and risk of non-alcoholic fatty liver disease	42
Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant	40
Nomogram for predicting overall survival in colorectal cancer with distant metastasis	39
Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease: a review	37
A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease	35
The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database	35
Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections	34
LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis	34
Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome	34
Establishment of prognostic nomogram for elderly colorectal cancer patients: a SEER database analysis	33
FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran	32
Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study	31
Use of BioFire FilmArray gastrointestinal PCR panel associated with reductions in antibiotic use, time to optimal antibiotics, and length of stay	31
Predictors of surgical site infection after pancreaticoduodenectomy	30
Beyond the scope and the glue: update on evaluation and management of gastric varices	29

Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF)	29
The diffuse-type gastric cancer epidemiology enigma	28
Association of Helicobacter pylori vacA genotypes and peptic ulcer in Iranian population: a systematic review and meta-analysis	27
Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study	27